Strand Therapeutics Funding & Investors
Strand Therapeutics is a developer of a biotechnology platform intended to create gene therapies powered by synthetic biology.The company's offerings include immunotherapies to help cells produce target cancer-killing proteins during immunotherapy, enabling patients to improve their body's immune system to fight cancer.
strandtx.comTotal Amount Raised: $104,200,000
Strand Therapeutics Funding Rounds
Series A
$45,000,000
Series A Investors
FPV VenturesPotentum PartnersEli Lilly And Company FoundationPlayground GlobalGrant
$400,000
Grant Investors
National Cancer InstituteGrant
$800,000
Grant Investors
National Cancer InstituteSeries A
$52,000,000
Series A Investors
BeiGeneRedmile GroupCamford CapitalANRIPlayground GlobalSeed
$6,000,000
Seed Investors
Creative Destruction LabAlexandria Real Estate EquitiesANRIPlayground Global
Funding info provided by Diffbot.